Search

everythinglearnresearchcommunity

for

Search:↓

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Micrografts can effectively restore pubic hair, and using the right technique is crucial for natural-looking results.

PCOS is linked to low-grade chronic inflammation.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Dhatryadi Rasayana, an Ayurvedic herbal mix, may be a safe and effective way to prevent premature hair greying.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Gene mutations can cause problems in male genital development.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

New understanding and treatments for hair loss are improving, but more research is needed.

Men may experience long-term sexual dysfunction after stopping Finasteride.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

Female hair loss patients more likely to have dry eye and gland issues.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

PCOS is a hormonal disorder in women that can cause infertility and increases the risk of heart and metabolic issues.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Certain medications can reduce sexual desire and function, especially in women.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.